COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,666 Articles (22,913 medRxiv, 8,753 bioRxiv)

Most recent first Previous |  Page 141: Articles 1401-1410  | Next

A truncated SARS-CoV-2 nucleocapsid protein enhances virus fitness by evading antiviral responses
Mulloy, R. P., Evseev, D., Bui-Marinos, M. P., Sharlin, N., Corcoran, J. A.
10.1101/2025.02.15.638421 — Posted: 2025-02-26
Forecasting protein evolution by integrating birth-death population models with structurally constrained substitution models
Ferreiro, D., Gonzalez-Vazquez, L. D., Prado-Comesana, A., Arenas, M.
10.1101/2025.02.21.639428 — Posted: 2025-02-26
Changes in pneumococcal deaths in the United States following the COVID-19 pandemic
Shang, L., Perniciaro, S., Weinberger, D.
10.1101/2025.02.24.25322782 — Posted: 2025-02-25
Pharmacokinetics of anti-SARS-CoV-2 monoclonal antibody SA55 injection in healthy participants
Zhou, Y., MENG, X., Li, J., Wang, J., Zeng, G., Cao, Y. R., Hu, C., Jin, R.
10.1101/2025.02.22.25322730 — Posted: 2025-02-24
NRF2 activators restrict coronaviruses by targeting a network involving ACE2, TMPRSS2, and XPO1
Waqas, F. H., Zapatero-Belinchon, F. J., Carter-Timofte, M. E., Lasswitz, L., van der Horst, D., Möller, R., Dahlmann, J., Olmer, R., Geffers, R., Gerold, G., Olagnier, D., Pessler, F.
10.1101/2025.02.24.639813 — Posted: 2025-02-24
SARS-CoV-2 nucleocapsid uniquely disrupts chromatin over pathophysiologically relevant gene promoters
Benoit, J. M., Dennis, J. H.
10.1101/2025.02.22.639619 — Posted: 2025-02-24
Flagellin in the human gut microbiome is a diet-adjustable adjuvant for vaccination
Huus, K. E., uHEAT Clinical Study Group, , Tan, Y. H., Abo, H., Keller, R., Atay, E., Vu, D. L., Dauser, S., Prokipchuk, A., Tyakht, A., Youngblut, N., Chassaing, B., Kang, S.-M., Parsonnet, J., Kremsner, P. G., Maier, L., Gewirtz, A. T., Esen, M., Ley, R. E.
10.1101/2025.02.21.639485 — Posted: 2025-02-24
Hematologic, Immunologic and Outcome Characteristics of Severe acute respiratory syndrome 2 (SARS-COV-2) among People Living with HIV in Eastern Uganda: A retrospective study
Otaala, T., Opito, R., Mugisha, K., Oryokot, B., Bakashaba, B., Esabu, M., Nbidde, S. N., Watmon, B., Etolu, W., Lubaale, M. Y., Olupot-Olupot, P.
10.1101/2025.02.22.25322708 — Posted: 2025-02-23
Food Insecurity and Food Practices among Child Care Workers During COVID-19
DYNIA, J., Koury, A. J., Bates, R. A.
10.1101/2025.02.20.25322598 — Posted: 2025-02-21
Estimates of underlying health biases in SARS-CoV-2 vaccination recipients: a nationwide study in previously-infected adults
Riedmann, U., Chalupka, A., Richter, L., Werber, D., Sprenger, M., Willeit, P., Rijksen, M., Lodron, J., Hoeg, T. B., Ioannidis, J., Pilz, S.
10.1101/2025.02.19.25322515 — Posted: 2025-02-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).